These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 15887855

  • 1. Growth hormone secretion in primary and secondary hyperparathyroidism.
    Cecconi E, Gasperi M, Genovesi M, Bogazzi F, Grasso L, Procopio M, Marcocci C, Pinchera A, Bartalena L, Martino E.
    J Endocrinol Invest; 2005 Feb; 28(2):113-6. PubMed ID: 15887855
    [Abstract] [Full Text] [Related]

  • 2. GH secretion is impaired in patients with primary hyperparathyroidism.
    Gasperi M, Cecconi E, Grasso L, Bartalena L, Centoni R, Aimaretti G, Broglio F, Miccoli P, Marcocci C, Ghigo E, Martino E.
    J Clin Endocrinol Metab; 2002 May; 87(5):1961-4. PubMed ID: 11994325
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impaired GH secretion to provocative stimuli in two families with hypocalciuric hypercalcaemia.
    Cecconi E, Bogazzi F, Cetani F, Grasso L, Marcocci C, Genovesi M, Procopio M, Gasperi M, Pinchera A, Ghigo E, Martino E.
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):604-6. PubMed ID: 14616884
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Primary hyperparathyroidism is associated with marked impairment of GH response to acylated ghrelin.
    Cecconi E, Bogazzi F, Morselli LL, Gasperi M, Procopio M, Gramaglia E, Broglio F, Giovannetti C, Ghigo E, Martino E.
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):197-201. PubMed ID: 18221398
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M, Bossoni S, Alí A, Doga M, Reimondo G, Milani G, Peretti P, Manelli F, Angeli A, Giustina A.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
    Alvarez P, Isidro L, Leal-Cerro A, Casanueva FF, Dieguez C, Cordido F.
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expanding the net: The re-evaluation of the multidimensional nomogram calculating the upper limit of normal PTH (maxPTH) in the setting of secondary hyperparathyroidism and the development of the MultIdimensional Predictive hyperparaTHyroid model (Mi-PTH).
    Rajhbeharrysingh U, El Youssef J, Leon E, Lasarev MR, Klein R, Vanek C, Mattar S, Berber E, Siperstein A, Shindo M, Milas M.
    Surgery; 2016 Jan; 159(1):226-39. PubMed ID: 26531237
    [Abstract] [Full Text] [Related]

  • 15. Distribution of circulating immunoreactive components of parathyroid hormone in normal subjects and in patients with primary and secondary hyperparathyroidism: the role of the kidney and of the serum calcium concentration.
    Dambacher MA, Fischer JA, Hunziker WH, Born W, Moran J, Roth HR, Delvin EE, Glorieux FH.
    Clin Sci (Lond); 1979 Nov; 57(5):435-43. PubMed ID: 519952
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Parathyroid hormone (PTH)/PTH-related protein receptor messenger ribonucleic acid expression and PTH response in a rat model of secondary hyperparathyroidism associated with vitamin D deficiency.
    Turner G, Coureau C, Rabin MR, Escoubet B, Hruby M, Walrant O, Silve C.
    Endocrinology; 1995 Sep; 136(9):3751-8. PubMed ID: 7649081
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D metabolism in familial benign hypercalcemia (hypocalciuric hypercalcemia) differs from that in primary hyperparathyroidism.
    Law WM, Bollman S, Kumar R, Heath H.
    J Clin Endocrinol Metab; 1984 Apr; 58(4):744-7. PubMed ID: 6699136
    [Abstract] [Full Text] [Related]

  • 19. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M, Salati B, Bianchi S, Rallo M, Tinelli C, Autelli M, Aimaretti G, Ghigo E.
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [Abstract] [Full Text] [Related]

  • 20. GH secretion in a cohort of children with pseudohypoparathyroidism type Ia.
    de Sanctis L, Bellone J, Salerno M, Faleschini E, Caruso-Nicoletti M, Cicchetti M, Concolino D, Balsamo A, Buzi F, Ghizzoni L, de Sanctis C.
    J Endocrinol Invest; 2007 Feb; 30(2):97-103. PubMed ID: 17392598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.